Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Mar 15, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of rehabilitation can help improve balance in patients with chronic demyelinating neuropathy, a condition that affects the nerves and can cause walking difficulties. The trial will involve 40 participants who experience instability while walking. They will be divided into two groups: one group will do balance exercises with their eyes open, while the other group will do the same exercises with their eyes closed or with their vision obstructed in various ways. Each participant will complete 20 sessions with a physical therapist and undergo three assessments to monitor their progress.
To be eligible for this study, participants must be at least 18 years old, able to walk 20 meters without assistance, and have been stable in their condition for at least two months. They should also be experiencing discomfort or instability while walking. However, those with certain conditions, such as severe balance issues from other causes or recent surgeries, may not qualify. This trial is being conducted in the Paris area, and all participants must be able to understand the instructions given in French. This study aims to find out whether adjusting visual input during rehabilitation can enhance the effectiveness of balance training for individuals with neuropathy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with chronic demyelinating acquired neuropathy
- • Age ≥ 18 years.
- • Patients able to walk 20 meters without human assistance at least indoors with or without technical assistance.
- • Patients with complaints such as discomfort, walking instability related to sensitivity disorders.
- • Patients being clinically stable for at least 2 months, regardless of ongoing treatments.
- • Patients who have provided consent.
- Exclusion Criteria:
- • Patients unable to walk 20 metres without technical and human assistance indoors.
- • Patients with an ongoing hospitalization.
- • Patients already included and participating in another intervention study.
- • Patients with ongoing balance rehabilitation and continued during the REQ-PRO program in another rehabilitation centre or practice.
- • Patients with ongoing acute treatment (related to polyneuropathy) started less than 2 months ago or stopped less than 2 months ago.
- • Patients with scheduled surgery during the period of the patient's participation in the protocol, preventing the successful completion of the rehabilitation program and participation in assessments.
- • Patients with recent surgery, in particular lower limb prosthesis (less than 1 year old) or equipment contraindicated for planned exercises such as standing kneeling positions.
- • Patients with skin wounds on the foot that contraindicate rehabilitation.
- • Patients with balance disorders of vestibular origin or central neurological pathology.
- • Patients with a visual disability.
- • Patients with a hearing impairment that prevents the patient from hearing and understanding instructions during the rehabilitation program or assessments.
- • Patients with an inability to speak or understand the French language.
- • Patients with cognitive or language impairments that prevent understanding of the protocol.
- • Patients with a residence outside of the Paris Region (Ile de France).
- • Patients with a known pregnancy.
- • Patients not affiliated to a social security system (beneficiary or having a right), deprived of their right, under guardianship, curatorship, prisoner.
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Bénédicte PANIGOT GUERIN, PT
Principal Investigator
Assistance Publique - Hôpitaux de Paris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials